Cargando…

Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival

BACKGROUND: The genetic changes in gastric adenocarcinoma are extremely complex and reliable tumor markers have not yet been identified. There are also remarkable geographical differences in the distribution of this disease. Our aim was to identify the most differentially regulated genes in 20 gastr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eftang, Lars L, Esbensen, Ying, Tannæs, Tone M, Blom, Gustav P, Bukholm, Ida RK, Bukholm, Geir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029627/ https://www.ncbi.nlm.nih.gov/pubmed/24321518 http://dx.doi.org/10.1186/1471-2407-13-586

Ejemplares similares

Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells
por: Eftang, Lars L, et al.
Publicado: (2012)

GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer
por: Eftang, Lars Lohne, et al.
Publicado: (2016)

In silico evolutionary analysis of Helicobacter pylori outer membrane phospholipase A (OMPLA)
por: Vollan, Hilde S, et al.
Publicado: (2012)

In Silico Structure and Sequence Analysis of Bacterial Porins and Specific Diffusion Channels for Hydrophilic Molecules: Conservation, Multimericity and Multifunctionality
por: Vollan, Hilde S., et al.
Publicado: (2016)

Outer membrane phospholipase A’s roles in Helicobacter pylori acid adaptation
por: Vollan, Hilde S., et al.
Publicado: (2017)

The Prognostic Impact of Protein Expression of E-Cadherin-Catenin Complexes Differs between Rectal and Colon Carcinoma
por: Aamodt, Rolf, et al.
Publicado: (2010)

Differences in Protein Expression and Gene Amplification of Cyclins between Colon and Rectal Adenocarcinomas
por: Aamodt, Rolf, et al.
Publicado: (2009)

The Prognostic Value and Overexpression of Cyclin A Is Correlated with Gene Amplification of both Cyclin A and Cyclin E in Breast Cancer Patient
por: Husdal, A., et al.
Publicado: (2006)

An observational study: associations between nurse-reported hospital characteristics and estimated 30-day survival probabilities
por: Tvedt, Christine, et al.
Publicado: (2014)

Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer
por: Sørby, Lise Aa, et al.
Publicado: (2010)

Protein expression and gene amplification of primary cyclins (A, B(1), D(1), D(3 )and E) and secondary cyclins (C and H) in relation to prognosis in breast cancer patients
por: Husdal, A, et al.
Publicado: (2005)

International health policy survey in 11 countries: assessment of non-response bias in the Norwegian sample
por: Bjertnaes, Oyvind A, et al.
Publicado: (2010)

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
por: Langerød, Anita, et al.
Publicado: (2007)

Two novel connexin32 mutations cause early onset X-linked Charcot-Marie-Tooth disease
por: Braathen, Geir J, et al.
Publicado: (2007)

Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer
por: Riis, Margit LH, et al.
Publicado: (2010)

A cross-sectional study to identify organisational processes associated with nurse-reported quality and patient safety
por: Tvedt, Christine, et al.
Publicado: (2012)

Down-Regulated CLDN10 Predicts Favorable Prognosis and Correlates With Immune Infiltration in Gastric Cancer
por: Rao, XiongHui, et al.
Publicado: (2021)

Usefulness of a national parent experience survey in quality improvement: views of paediatric department employees
por: Iversen, Hilde Hestad, et al.
Publicado: (2010)

Monitoring adverse events in Norwegian hospitals from 2010 to 2013
por: Deilkås, Ellen Tveter, et al.
Publicado: (2015)

A systematic review of hospital accreditation: the challenges of measuring complex intervention effects
por: Brubakk, Kirsten, et al.
Publicado: (2015)

Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age
por: Storli, Kristian E., et al.
Publicado: (2011)

Analysis of the expression and genetic alteration of CLDN18 in gastric cancer
por: Li, Jian, et al.
Publicado: (2020)

Compensation after treatment for anterior cruciate ligament injuries: a review of compensation claims in Norway from 2005 to 2015
por: Randsborg, Per-Henrik, et al.
Publicado: (2017)

Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis
por: Fjaerli, Hans-Olav, et al.
Publicado: (2006)

The Generic Short Patient Experiences Questionnaire (GS-PEQ): identification of core items from a survey in Norway
por: Sjetne, Ingeborg Strømseng, et al.
Publicado: (2011)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

Compensation claims in pediatric orthopedics in Norway between 2012 and 2018: a nationwide study of 487 patients
por: Horn, Joachim, et al.
Publicado: (2021)

Patients Who Die by Suicide: A Study of Treatment Patterns and Patient Safety Incidents in Norway
por: Krvavac, Sanja, et al.
Publicado: (2022)

Characteristics of Patients Who Complete Suicide and Suicide Attempts While Undergoing Treatment in Norway: Findings from Compensation Claims Records
por: Krvavac, Sanja, et al.
Publicado: (2023)

Enrichment of CLDN18‐ARHGAP fusion gene in gastric cancers in young adults
por: Nakayama, Izuma, et al.
Publicado: (2019)

Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
por: Kwon, Mi Jeong, et al.
Publicado: (2010)

Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family
por: Gao, Peipei, et al.
Publicado: (2021)

Ureteric injuries during hysterectomy—A Norwegian retrospective study of occurrence and claims for compensation over an 11‐year period
por: Ravlo, Merethe, et al.
Publicado: (2021)

CLDN1 regulates trophoblast apoptosis and proliferation in preeclampsia
por: Zhang, Yu-chen, et al.
Publicado: (2021)

Expression of CLDN6 in tissues of gastric cancer patients: Association with clinical pathology and prognosis
por: Gao, Fangmei, et al.
Publicado: (2019)

Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer
por: Kim, Seo Ree, et al.
Publicado: (2020)

CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer
por: Wang, Canming, et al.
Publicado: (2023)

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells
por: Lu, Yan, et al.
Publicado: (2021)

The IL1β-HER2-CLDN18/CLDN4 axis mediates lung barrier damage in ARDS
por: Ma, Xinhua, et al.
Publicado: (2020)

Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
por: McDermott, Martina S.J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q769ls0tgea4ej8ep9he9sas65